Cited 0 time in
Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zhang, Yiwen | - |
| dc.contributor.author | Lee, Donghoon | - |
| dc.contributor.author | Leandro F. M. Rezende | - |
| dc.contributor.author | Keum, Nana | - |
| dc.contributor.author | Giovannucci, Edward L. | - |
| dc.date.accessioned | 2025-11-28T07:30:53Z | - |
| dc.date.available | 2025-11-28T07:30:53Z | - |
| dc.date.issued | 2025-12 | - |
| dc.identifier.issn | 2374-2437 | - |
| dc.identifier.issn | 2374-2445 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/62162 | - |
| dc.description.abstract | Importance: Growing evidence suggests that physical activity protects against digestive system cancers (DSCs). However, it remains largely unknown whether consistently reaching the physical activity guidelines (≥7.5 metabolic equivalent task [MET]-hours/week) is associated with lower DSC risk or whether a much higher level is needed. Objective: To examine the association between physical activity and DSC risk and mortality with a focus on the optimal amount and long-term consistency in performing the recommended level over a long period of time. Design, Setting, and Participants: This population-based cohort study includes data from 3 large US prospective cohorts: Health Professionals Follow-Up Study, 1988-2020; Nurses' Health Study, 1988-2021; and Nurses' Health Study II, 1991-2021. Data analysis was performed between October 2024 and May 2025. Participants were men and women free from cancer and cardiovascular disease at baseline. Exposures: Total levels of leisure-time physical activity were assessed with biennial validated questionnaires and expressed in MET-hours per week. Consistency was calculated as the percentage of follow-up years meeting the recommended level (≥7.5 MET-hours/week). Main Outcomes and Measures: DSCs included cancers of digestive tract (mouth, throat, esophagus, stomach, small intestine, colon, and rectum) and digestive accessory organs (pancreas, gallbladder, and liver). Results: During up to 32 years of follow-up of 231067 men and women (median age, 43 [IQR, 36-55] years), a total of 6538 incident DSCs and 3791 DSC deaths were documented. Higher physical activity levels were associated with lower DSC risk (≥45 vs <3 MET-hours/week; hazard ratio [HR], 0.83; 95% CI, 0.74-0.93; P <.001 for trend) and mortality (HR, 0.72; 95% CI, 0.62-0.83; P <.001 for trend). The inverse associations were evident for both digestive tract and accessory organ cancers: the HRs comparing greater than or equal to 45 vs 3 MET-hours/week were 0.85 (95% CI, 0.75-0.97) for digestive tract cancer risk and 0.73 (95% CI, 0.58-0.92) for digestive accessory organ cancer risk. The traditional dose-response analysis suggested the lowest DSC risk was achieved at approximately 50 MET-hours/week. However, when long-term consistency was considered, compared with those with minimal activity, consistently reaching the guideline at moderate levels (median, 16.9 [IQR, 13.6-20.5] MET-hours/week) over 3 decades was associated with substantial reductions in DSC risk (HR, 0.83; 95% CI, 0.75-0.90), whereas that performing much higher amounts (median, 38.5 [IQR, 28.5-53.8] MET-hours/week) was not associated with further benefit (HR, 0.87; 95% CI, 0.81-0.93). Conclusions and Relevance: In this study, traditional dose-response analysis suggested that approximately 50 MET-hours/week was associated with optimal DSC risk reduction. After incorporating long-term consistency, maintenance of a moderate level approximately 17 MET-hours/week over 3 decades was associated with achieving optimal benefit in reducing DSC risk. © 2025 Elsevier B.V., All rights reserved. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | American Medical Association | - |
| dc.title | Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1001/jamaoncol.2025.4185 | - |
| dc.identifier.scopusid | 2-s2.0-105021613477 | - |
| dc.identifier.wosid | 001626473900001 | - |
| dc.identifier.bibliographicCitation | JAMA Oncology, v.11, no.12, pp 1488 - 1496 | - |
| dc.citation.title | JAMA Oncology | - |
| dc.citation.volume | 11 | - |
| dc.citation.number | 12 | - |
| dc.citation.startPage | 1488 | - |
| dc.citation.endPage | 1496 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | REPRODUCIBILITY | - |
| dc.subject.keywordPlus | VALIDITY | - |
| dc.subject.keywordPlus | QUESTIONNAIRE | - |
| dc.subject.keywordPlus | ASSOCIATION | - |
| dc.subject.keywordPlus | PREVENTION | - |
| dc.subject.keywordPlus | VALIDATION | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
